Afferent and Efferent Visual Markers of Alzheimer's Disease: A Review and Update in Early Stage Disease
- PMID: 33061906
- PMCID: PMC7518395
- DOI: 10.3389/fnagi.2020.572337
Afferent and Efferent Visual Markers of Alzheimer's Disease: A Review and Update in Early Stage Disease
Abstract
Vision, which requires extensive neural involvement, is often impaired in Alzheimer's disease (AD). Over the last few decades, accumulating evidence has shown that various visual functions and structures are compromised in Alzheimer's dementia and when measured can detect those with dementia from those with normal aging. These visual changes involve both the afferent and efferent parts of the visual system, which correspond to the sensory and eye movement aspects of vision, respectively. There are fewer, but a growing number of studies, that focus on the detection of predementia stages. Visual biomarkers that detect these stages are paramount in the development of successful disease-modifying therapies by identifying appropriate research participants and in identifying those who would receive future therapies. This review provides a summary and update on common afferent and efferent visual markers of AD with a focus on mild cognitive impairment (MCI) and preclinical disease detection. We further propose future directions in this area. Given the ease of performing visual tests, the accessibility of the eye, and advances in ocular technology, visual measures have the potential to be effective, practical, and non-invasive biomarkers of AD.
Keywords: Alzheimer’s disease; afferent visual system; efferent visual system; mild cognitive impairment; optical coherence tomography; pupillometry; saccadic eye movement; visual biomarkers.
Copyright © 2020 Wu, Masurkar and Balcer.
Figures

Similar articles
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Rev Neurol (Paris). 2012. PMID: 22579080 Review. French.
-
Visual Search Efficiency in Mild Cognitive Impairment and Alzheimer's Disease: An Eye Movement Study.J Alzheimers Dis. 2020;75(1):261-275. doi: 10.3233/JAD-190690. J Alzheimers Dis. 2020. PMID: 32250291
-
Ultra-Early Screening of Cognitive Decline Due to Alzheimer's Pathology.Biomedicines. 2023 May 11;11(5):1423. doi: 10.3390/biomedicines11051423. Biomedicines. 2023. PMID: 37239094 Free PMC article. Review.
-
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018. Alzheimers Dement. 2018. PMID: 29653606 Free PMC article. Review.
Cited by
-
Early visual alterations in individuals at-risk of Alzheimer's disease: a multidisciplinary approach.Alzheimers Res Ther. 2023 Jan 24;15(1):19. doi: 10.1186/s13195-023-01166-0. Alzheimers Res Ther. 2023. PMID: 36694201 Free PMC article.
-
Characterization of the angular gyrus in an older adult population: a multimodal multilevel approach.Brain Struct Funct. 2023 Jan;228(1):83-102. doi: 10.1007/s00429-022-02529-3. Epub 2022 Jul 29. Brain Struct Funct. 2023. PMID: 35904594 Free PMC article.
-
Automated High-Definition MRI Processing Routine Robustly Detects Longitudinal Morphometry Changes in Alzheimer's Disease Patients.Front Aging Neurosci. 2022 Jun 7;14:832828. doi: 10.3389/fnagi.2022.832828. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35747446 Free PMC article.
-
The bidirectional relationship between subjective visual function and domain-specific cognition in cognitively unimpaired older adults and adults with mild cognitive impairment.Front Aging Neurosci. 2024 Nov 29;16:1465812. doi: 10.3389/fnagi.2024.1465812. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39679257 Free PMC article.
-
Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from Normal Aging.Dement Geriatr Cogn Disord. 2025 Jun 11:1-12. doi: 10.1159/000546451. Online ahead of print. Dement Geriatr Cogn Disord. 2025. PMID: 40499520 Free PMC article.
References
-
- Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. . (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
-
- Almeida A. L. M., Pires L. A., Figueiredo E. A., Costa-Cunha L. V. F., Zacharias L. C., Preti R. C., et al. . (2019). Correlation between cognitive impairment and retinal neural loss assessed by swept-source optical coherence tomography in patients with mild cognitive impairment. Alzheimers Dement. 11, 659–669. 10.1016/j.dadm.2019.08.006 - DOI - PMC - PubMed
-
- Alzheimer’s Disease Facts and Figures (2019). Alzheimer’s Association. Available online at: www.alz.org/facts/. Accessed April 9, 2019.
Grants and funding
LinkOut - more resources
Full Text Sources